Victory Capital Management Inc. raised its stake in shares of Merit Medical Systems Inc. (NASDAQ:MMSI) by 2.5% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 63,461 shares of the company’s stock after buying an additional 1,567 shares during the period. Victory Capital Management Inc. owned about 0.14% of Merit Medical Systems worth $1,257,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in MMSI. I.G. Investment Management LTD. boosted its stake in shares of Merit Medical Systems by 1.9% in the second quarter. I.G. Investment Management LTD. now owns 97,715 shares of the company’s stock valued at $1,938,000 after buying an additional 1,841 shares during the last quarter. GSA Capital Partners LLP boosted its stake in shares of Merit Medical Systems by 13.9% in the second quarter. GSA Capital Partners LLP now owns 109,789 shares of the company’s stock valued at $2,177,000 after buying an additional 13,378 shares during the last quarter. Aristotle Capital Boston LLC boosted its stake in shares of Merit Medical Systems by 4.8% in the first quarter. Aristotle Capital Boston LLC now owns 410,409 shares of the company’s stock valued at $7,588,000 after buying an additional 18,797 shares during the last quarter. Fisher Asset Management LLC boosted its stake in shares of Merit Medical Systems by 8.7% in the first quarter. Fisher Asset Management LLC now owns 185,797 shares of the company’s stock valued at $3,660,000 after buying an additional 14,810 shares during the last quarter. Finally, Arizona State Retirement System boosted its stake in shares of Merit Medical Systems by 4.6% in the first quarter. Arizona State Retirement System now owns 22,744 shares of the company’s stock valued at $421,000 after buying an additional 1,000 shares during the last quarter. Institutional investors and hedge funds own 87.00% of the company’s stock.

Shares of Merit Medical Systems Inc. (NASDAQ:MMSI) traded down 0.74% during midday trading on Wednesday, reaching $24.05. 112,122 shares of the company traded hands. The stock’s 50-day moving average is $23.91 and its 200-day moving average is $20.61. The stock has a market capitalization of $1.07 billion, a P/E ratio of 47.16 and a beta of 0.80. Merit Medical Systems Inc. has a 1-year low of $15.47 and a 1-year high of $25.50.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Wednesday, July 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. The business had revenue of $151.07 million for the quarter, compared to analyst estimates of $147.76 million. Merit Medical Systems had a net margin of 4.06% and a return on equity of 8.43%. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period last year, the firm posted $0.25 earnings per share. Equities analysts predict that Merit Medical Systems Inc. will post $0.99 EPS for the current fiscal year.

MMSI has been the subject of several analyst reports. Zacks Investment Research upgraded shares of Merit Medical Systems from a “sell” rating to a “hold” rating in a research note on Friday, June 10th. Canaccord Genuity initiated coverage on shares of Merit Medical Systems in a research note on Tuesday, July 19th. They issued a “buy” rating and a $27.00 target price for the company. Finally, Barrington Research cut shares of Merit Medical Systems from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 28th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $23.20.

In other news, Director Richard W. Edelman sold 21,500 shares of the firm’s stock in a transaction that occurred on Friday, August 12th. The shares were sold at an average price of $23.51, for a total transaction of $505,465.00. Following the transaction, the director now directly owns 20,682 shares in the company, valued at $486,233.82. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Nolan E. Karras sold 5,878 shares of the firm’s stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $23.35, for a total transaction of $137,251.30. Following the transaction, the director now owns 5,878 shares in the company, valued at $137,251.30. The disclosure for this sale can be found here. Insiders own 5.60% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a designer, developer, manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures. The Company operates in two segments: cardiovascular and endoscopy. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases; embolotherapeutic products, and cardiac rhythm management and electrophysiology (CRM/EP) devices.

5 Day Chart for NASDAQ:MMSI

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems Inc. (NASDAQ:MMSI).

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.